Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
55981-09-4CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1YQNQNVDNTFHQSW-UHFFFAOYSA-N55981-09-4DTXSID5033757CHEMBL1401CHEBI:94807Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
BeschreibungNitazoxanide (NT Z) has been approved as an orphan drug for the treatment of diarrhea in children (age, 1–11 years) and is associated with giardiasis, but it also is approved for diarrhea caused by crytosporidiosis in patients with AIDS. Crytosporidiosis is a protozoal infection caused by Cryptosporidi um parvum. The condition is uncommon in healthy individuals but can be life-threatening in immunosuppressed patients and those with HIV infections.
VerwendenNitazoxanide has been used: to test its anti-viral activity against chikungunya virusas an antiprotozoal agent to test its effect on cell viability in various cancer cell linesto test its effect on human cytomegalovirus (HCMV) infected human fibroblast HFF cells
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…